Meharry Medical College

RISE announces finalists for 2024 Health Care Hero Award

Retrieved on: 
Saturday, March 16, 2024
Meharry Medical College, Social, Health equity, Patient, HCSC, The, Nursing

NEW ORLEANS, March 16, 2024 /PRNewswire/ -- RISE is pleased to announce the finalists for the 2024 RISE Health Care Hero Award. The prestigious honor, presented annually at The RISE Summit on Social Determinants of Health, acknowledges an individual's effort to make a significant impact on the lives of underserved populations through health care and/or social services interventions, and through superior example of the RISE mission to promote health equity among all patients.

Key Points: 
  • RISE has narrowed the impressive candidate pool of nearly 60 nominations to the top five finalists.
  • NEW ORLEANS, March 16, 2024 /PRNewswire/ -- RISE is pleased to announce the finalists for the 2024 RISE Health Care Hero Award.
  • The prestigious honor, presented annually at The RISE Summit on Social Determinants of Health, acknowledges an individual's effort to make a significant impact on the lives of underserved populations through health care and/or social services interventions, and through superior example of the RISE mission to promote health equity among all patients.
  • The 2024 award recipient will be announced at The RISE Summit on Social Determinants of Health in New Orleans on Tuesday, April 16, the second day of the three-day conference.

Henry Schein, National Dental Association and Schattner Foundation Present Student Mentoring Program for Aspiring Dental Professionals

Retrieved on: 
Wednesday, February 21, 2024
Dental, Professional Services, Other Education, Continuing, Training, General Health, Health, Primary, Secondary, Environmental, Social and Governance (ESG), Education, National Dental Association, Student, Enrichment, Multimedia, Metropolitan, Dentist, Dental hygienist, Mentorship, Washington Metro, Meharry Medical College, Howard University, Society, University, Maryland School, Health literacy, Health equity, NDA, Hygiene, Partnership

Henry Schein, Inc. (Nasdaq: HSIC), National Dental Association (NDA), and Schattner Foundation are pleased to partner and present the S.M.I.L.E.

Key Points: 
  • Henry Schein, Inc. (Nasdaq: HSIC), National Dental Association (NDA), and Schattner Foundation are pleased to partner and present the S.M.I.L.E.
  • This innovative public-private partnership is designed to mentor and support aspiring healthcare professionals and enhance inclusivity within the dental field.
  • Joining Henry Schein, the NDA, and Schattner Foundation in presenting the 2024 program are the Hispanic Dental Association, the Society of American Indian Dentists, Meharry Medical College School of Dentistry, and the A.T.
  • The program was made possible by a generous grant from the Schattner Foundation and the support of other professional organizations.

Genprex Expands Nonclinical Programs into New Therapeutic Indications with Research Collaborators

Retrieved on: 
Wednesday, February 7, 2024
Transfer, AACR, TUSC2, Toxicity, Survival, Cell, Research, NSCLC, DNA, NPRL2, Mitochondrion, Lung cancer, Gene, Patient, FDA, ALK, Mouse, Food, Crizotinib, Diabetes, Risk, Biology, Metabolism, Meharry Medical College, Cancer, University, Malignancy, Vaccine

AUSTIN, Texas, Feb. 7, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced the expansion of its nonclinical programs into new indications through Sponsored Research Agreements and Material Transfer Agreements with multiple academic research collaborators to study TUSC2, the tumor suppressor gene used in Genprex's lead drug candidate, REQORSA (quaratusugene ozeplasmid), and NPRL2, another tumor suppressor gene. The new indications being evaluated include ALK-positive lung cancer and other additional programs that are not disclosed at this time.

Key Points: 
  • The new indications being evaluated include ALK-positive lung cancer and other additional programs that are not disclosed at this time.
  • "Research indicates that the TUSC2 gene used in REQORSA may benefit many types of cancers and potentially the treatment of other diseases.
  • Research collaborators at the Rogel Cancer Center's Judith Tam ALK Lung Cancer Research Initiative are studying the combination of Genprex's REQORSA, which uses the TUSC2 tumor suppressor gene, with various ALK inhibitors.
  • Genprex believes this system allows for delivery of a number of cancer-fighting genes, alone or in combination with other cancer therapies, to combat multiple types of cancer.

Overcoming 'Otherness' in Scientific Research Commentary in Nature Human Behavior

Retrieved on: 
Friday, February 2, 2024
Science, HHO, Nature Human Behaviour, Bioethics, National Alliance, Meharry Medical College, Algorithm, Tuskegee University, Movement

Dr. Delgado explains further, "True scientific excellence requires all voices, and varied experiences and perspectives.

Key Points: 
  • Dr. Delgado explains further, "True scientific excellence requires all voices, and varied experiences and perspectives.
  • To harness the full potential of our society, we must recognize and actively address the biases that 'otherness' introduces into scientific research."
  • The commentary highlights the detrimental impact of 'otherness' in scientific methodologies and outcomes, particularly in health-related research.
  • For the full commentary, please visit Nature Human Behavior: https://www.nature.com/articles/s41562-024-01821-y

Author and Health Equity Leader Daniel E. Dawes, J.D., to Keynote Inaugural Health Summit

Retrieved on: 
Thursday, January 18, 2024
Senior, Meharry Medical College, Health, TIP, Arm, COVID-19, Intersection, Politics

A recognized leader in the health equity movement, Dawes is most known for for his best-selling books, “150 Years of Obamacare” and “The Political Determinants of Health.” He currently serves as the Senior Vice President, Global Health & Executive Director of the Global Health Equity Institute at Meharry Medical College.

Key Points: 
  • A recognized leader in the health equity movement, Dawes is most known for for his best-selling books, “150 Years of Obamacare” and “The Political Determinants of Health.” He currently serves as the Senior Vice President, Global Health & Executive Director of the Global Health Equity Institute at Meharry Medical College.
  • “Creating and investing in healthy communities touches every aspect of public health today.
  • This summit addresses those diverse intersections,” said TIP Executive Director Terri Burke.
  • For more information about schedules, accommodations and early-bird pricing — available through March 4 — visit https://immunizeusa.org/intersection-summit/ .

FREE ADMISSION ON KING DAY AT THE NATIONAL CIVIL RIGHTS MUSEUM

Retrieved on: 
Tuesday, January 9, 2024
Overton High School, FedEx, Volunteering, Meharry Medical College, Health equity, National Civil Rights Museum, Partnership, The Home Depot, Sport, Reconciliation, COVID-19, Pavilion, Tata Daewoo, Organization, Wells Fargo, NFL, Vaccine, Ford Motor Company, Tourism

Thanks to the generous support of FedEx, admission to the museum on King Day will be free for all guests.

Key Points: 
  • Thanks to the generous support of FedEx, admission to the museum on King Day will be free for all guests.
  • A portion of the King Day program will livestream on the museum’s website from 11:30-1:30 pm Central with reflections on Dr. King and the holiday with entertainment.
  • Several corporations and organizations have committed volunteers to serve at the museum on King Day.
  • For more information about King Day events and activities at the National Civil Rights Museum, visit kingday.org .

Regeneron Commits $34 Million Over Five Years to Continue to Sponsor the Regeneron International Science and Engineering Fair (ISEF)

Retrieved on: 
Monday, November 13, 2023
Together for Change, Meharry Medical College, Research, STEM, Engineering, Science education, Science News, Mathematics, Canadian International Council, STS, Disease, Regeneron Science Talent Search, Student, Ecosystem, Chairperson, ISEF, News, Partnership, Female, Education, Pharmaceutical industry, Management, Science, Regeneron Pharmaceuticals, Society

TARRYTOWN, N.Y. and WASHINGTON, D.C., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (Society) today announced that Regeneron is increasing and extending its commitment as the title sponsor of the Regeneron International Science and Engineering Fair (ISEF), the world’s largest high school science and engineering competition, with a total investment of approximately $34 million over a five-year period.

Key Points: 
  • Each year, over 175,000 students compete in the Society's 400 affiliated high school science fairs around the world.
  • Top winners earn the right to compete at Regeneron ISEF where nearly 1,600 finalists, half of whom are young female scientists, are judged in 22 different categories.
  • The renewed sponsorship builds on Regeneron and the Society's long-standing partnership to advance STEM education, including through Regeneron's $100 million, ten-year commitment to the Regeneron Science Talent Search (STS), the nation’s oldest and most prestigious high school science and mathematics competition.
  • These high school science competitions play a pivotal role in directing high school students towards STEM careers.

 Virpax Pharmaceuticals Announces Leadership Transition

Retrieved on: 
Friday, November 17, 2023
Biotechnology, Health, Finance, Other Health, Pharmaceutical, Surgery, Professional Services, Other Science, Practice Management, Medical Devices, Infectious Diseases, Hospitals, Science, Veterinary, CNS, Neurogenic inflammation, Silence Therapeutics, Meharry Medical College, Pharmaceutical marketing, Regulatory affairs, Therapy, Post-traumatic stress disorder, Quality assurance, Lincoln University, Commercial Operating System, Pain management, Patient, INSEAD, Merck, Medication, Clobazam, Nitrome, Sanofi, Trustee, Novartis, University, Harvard Medical School, Axovant Sciences, Tennessee State University, Champaign–Urbana metropolitan area, Central nervous system, Business, DSM-IV codes, International business, Pharmaceutical industry, Management, Analgesic, Schizophrenia, Biology, Neurophysiology, Lundbeck, Neuroscience, Droxidopa

Prior to Virpax, Mr. Bruce served as Vice President of sales for Danone Specialized Nutrition North America, Danone’s medical nutrition division.

Key Points: 
  • Prior to Virpax, Mr. Bruce served as Vice President of sales for Danone Specialized Nutrition North America, Danone’s medical nutrition division.
  • He has a BA from Lincoln University and a Master’s degree in Leadership from Georgetown University’s McDonough School of Business.
  • Aside from Virpax Pharmaceuticals, he also serves on the board of Advent Therapeutics Inc. and is a member of the Board of Trustees of Meharry Medical College.
  • I am proud of what we have accomplished together and confident that Virpax under Gerald and Eric’s leadership will remain on track to begin first-in-human trials in the coming year,” commented Mr. Mack.

Meharry Medical College Launches Nation’s First School of Global Health

Retrieved on: 
Monday, November 13, 2023
Diabetes, Health, Other Health, Training, Other Education, Continuing, University, Practice Management, Managed Care, Education, General Health, Hospitals, Fitness & Nutrition, Nursing, JD, Social, Global health, Health equity, STEM, DHL, Meharry Medical College, Global Health, Congress, Trustee, MBA, Mental health, Medical college, The Kresge Foundation, Knowledge, School, CVS Health, HIV, Behavioural sciences, American Public Health Association, Doctor of Public Health, Public health, PEPFAR, CVS Caremark, Female, Public, Medicine, Student, MCP, Accreditation, HBCU, Together for Change, BSPH, Research, Policy, Hope, LLP, FACC, Morehouse School of Medicine, Faculty, COVID-19, MPH, Human, Management, Pharmaceutical industry, Doctor of Philosophy

Meharry Medical College is advancing its work to eliminate global health inequities by establishing the first School of Global Health in the United States.

Key Points: 
  • Meharry Medical College is advancing its work to eliminate global health inequities by establishing the first School of Global Health in the United States.
  • The School is an outgrowth of the Institute of Global Health Equity, which Meharry launched in February of 2023.
  • The Meharry Board of Trustees unanimously approved Meharry establishing the School of Global Health at a meeting in October.
  • "As a former president of Meharry Medical College, it brings me great joy to witness the launch of the School of Global Health, which will be a global health equity pioneer," said Dr. David Satcher, the 16th U.S.

Tigerlily Foundation and Labcorp Launch I AM INCLUDED Framework to Increase Clinical Trial Diversity, Accelerate Delivery of Innovative Cancer Treatments

Retrieved on: 
Thursday, November 16, 2023
UCSF School of Medicine, Health equity, Meharry Medical College, Labcorp, Food, National Cancer Institute, Tigerlily, Morehouse School of Medicine, Disease, Duke Cancer Institute, Clinical trial, Mortality, Breast cancer, NCI, Patient, FDA, Person, Partnership, Pharmaceutical industry, Nursing, University, BURLINGTON

BURLINGTON, N.C. and WASHINGTON, Nov. 16, 2023 /PRNewswire/ -- Today, the Tigerlily Foundation (Tigerlily), a leading breast cancer patient advocacy organization, and Labcorp , a global leader of innovative and comprehensive laboratory services, announced the launch of I AM INCLUDED , a co-developed, modernized, multi-stakeholder framework for sharing best practices of U.S. diverse clinical trial site leaders for inclusive cancer clinical trials.

Key Points: 
  • BURLINGTON, N.C. and WASHINGTON, Nov. 16, 2023 /PRNewswire/ -- Today, the Tigerlily Foundation (Tigerlily), a leading breast cancer patient advocacy organization, and Labcorp , a global leader of innovative and comprehensive laboratory services, announced the launch of I AM INCLUDED , a co-developed, modernized, multi-stakeholder framework for sharing best practices of U.S. diverse clinical trial site leaders for inclusive cancer clinical trials.
  • Labcorp and Tigerlily then jointly hosted Patient Listening and Clinical Site Listening Summits to discuss health equity and diversity in cancer clinical trials.
  • Following the listening summits, I AM INCLUDED was developed as a transformational, actionable framework to provide proven and successful actions and serve as a guide for clinical trial site leaders to diversify enrollment in clinical research.
  • "Partnership without action is just admiring the problem," said Maimah Karmo, founder and CEO, Tigerlily Foundation.